Category: Vaccines
Global Vaccines
-
The 2023-2028 World Outlook for Subunit Animal Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Vaccine Adjuvants
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Veterinary and Animal Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for COVID-19 Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Opportunity Assessment of RNA-Based Therapeutics and Vaccines
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2023-2028 World Outlook for Polysaccharide Meningococcal Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Recombinant Animal Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Therapeutic Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Toxoid Animal Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Vaccines
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2023-2028 World Outlook for Vaccine Technologies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Anti-Hepatitis Drugs and Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Cholera Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Enteric Disease Diagnostics and Preventative Vaccines
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2023-2028 World Outlook for Mono Hepatitis B Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Live Attenuated Animal Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Human and Animal Vaccine Adjuvants
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Inactivated Animal Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Isothermal Boxes for Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Influenza a (H1N1) Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
Dengue Vaccines Market, By End User (Hospitals, Government Institutes, NGOs), and By Region (Latin America, Middle East, Africa, and Rest of World) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... a mosquito-borne viral infection causing a severe flu-like illness. Dengue vaccine is only recommended in those who have previously had dengue fever. It is given as three injections over a year. Dengue is most likely ... Read More
-
Global Exosome Research Market Size Study, ByProduct &Service(IndicationIon Animal, Companion Animal) By Indication(Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Equipment &Disposables, Others) By Application(Retail, E-Commerce, Veterinary Hospitals &Clinics) By End User (Reference Laboratories, Point-Of-Care Testing/In-House Testing, Veterinary Hospitals &Clinics, Others) And Regional Forecasts 2022-2028
... Veterinary Hospitals &Clinics, Others) And Regional Forecasts 2022-2028 Global Exosome ResearchMarket is valued approximately USD XXbillion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast ... Read More
-
Vaccine Adjuvants Market Forecasts to 2028 – Global Analysis By Type (Virus-like Particles, Tensoactive Adjuvants, Organic Adjuvants), Product (Adjuvant Emulsions, Combination Adjuvants), Disease Type (Cancer, Infectious Diseases) and By Geography
... Global Vaccine Adjuvants Market is accounted for $791.00 million in 2021 and is expected to reach $2,040.87 million by 2028 growing at a CAGR of 14.5% during the forecast period. Adjuvants are fundamentally compounds that ... Read More
-
Global mRNA Vaccines & Therapeutics Market 2022-2028
... with the potential to treat a wide variety of diseases with high unmet medical needs. The global mRNA vaccines & therapeutics market market is projected to decline by USD 34 million by 2028, according to ... Read More
-
Downstream Processing Market By Technology (Purification, Separation, Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Membrane Adsorbers, Other Products), By System (Single Use System, Re Usable System), By Application (Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, Other Applications), By End User (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs)): Global Opportunity Analysis and Industry Forecast, 2020-2030
... Production, Immunoglobulin Production, Erythropoietin Production, Other Applications), By End User (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs)): Global Opportunity Analysis and Industry Forecast, 2020-2030 Downstream processing refers to the recovery and purification of biosynthetic products, particularly ... Read More
Research Assistance
